Approvals/TGA/ABISART HCTZ 300/12.5 irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet blister pack

Approved

STANDARD

ABISART HCTZ 300/12.5 irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet blister pack

Sun Pharma ANZ Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: ac39eb47bae3ffd6
Product Name: ABISART HCTZ 300/12.5 irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet blister pack
Artg Id: 302148
Artg Name: ABISART HCTZ 300/12.5 irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet blister pack
Sponsor: Sun Pharma ANZ Pty Ltd
Company Detail Path: /organization/sun-pharma-anz-pty-ltd
Artg Date: 2018-11-06
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-CMI-01294-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-PI-02495-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

ac39eb47bae3ffd6

Type

Standard